The life sciences and diagnostics company posted sales of $6.05 billion and stands to benefit from an increase in ...

Vermont Business Magazine Finance Committee members Senator Peter Welch (D-Vermont) and Catherine Cortez Masto (D-Nev.), alongside Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today ...

While much of Washington remains shut down, Virginia just landed another multibillion-dollar pharmaceutical investment, this time from Merck. Gov. Glenn Youngkin announced Monday that Merck will ...

Hayden Lee, a student at Cedarville University, has been appointed as a student board member of the U.S. Sports Pharmacy ...

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

The adoption of artificial intelligence (AI) has accelerated, yet its impact on R&D productivity remains underwhelming.

Pharmaceutical drug discovery and development have grown increasingly difficult over the years. Yes, there have been great breakthroughs in technology that can facilitate research processes and the ...

In this interview, Braj Panda shares how Industry 5.0 is ushering in a future where technology doesn’t just optimise—it ...

Singapore-based pharmaceutical companies are seeking clarity on tariff exemptions amid new US tariffs, impacting billions in ...

Pharmacists deliver life-changing healthcare. Their compassionate guidance educates patients on how to make the safest and best use of their prescribed medications. The University of Wyoming School of ...

MFN-driven drug price reductions in the US are unlikely to have a big impact pharma R&D spending, experts agree.

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...